NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 254 filers reported holding NEOGENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,796 | -23.5% | 29,333 | 0.0% | 0.03% | -38.2% |
| Q2 2023 | $471,381 | -7.7% | 29,333 | 0.0% | 0.06% | -9.8% |
| Q1 2023 | $510,688 | +88.4% | 29,333 | 0.0% | 0.06% | +69.4% |
| Q4 2022 | $271,037 | +7.1% | 29,333 | 0.0% | 0.04% | -5.3% |
| Q3 2022 | $253,000 | +5.9% | 29,333 | 0.0% | 0.04% | +5.6% |
| Q2 2022 | $239,000 | -34.5% | 29,333 | -2.3% | 0.04% | -25.0% |
| Q1 2022 | $365,000 | -63.5% | 30,030 | +2.4% | 0.05% | -63.9% |
| Q4 2021 | $1,001,000 | -29.3% | 29,333 | 0.0% | 0.13% | -34.8% |
| Q3 2021 | $1,415,000 | +6.9% | 29,333 | 0.0% | 0.20% | +26.7% |
| Q2 2021 | $1,324,000 | -6.4% | 29,333 | 0.0% | 0.16% | -30.9% |
| Q1 2021 | $1,414,000 | -13.4% | 29,333 | -3.3% | 0.23% | -32.1% |
| Q4 2020 | $1,633,000 | – | 30,333 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |